Pharma-Bio Serv Gross Margin 2012-2026 | PBSV
Current and historical gross margin for Pharma-Bio Serv (PBSV) over the last 10 years. The current gross profit margin for Pharma-Bio Serv as of July 31, 2026 is %.
| Pharma-Bio Serv Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-07-31 | $0.01B | $0.00B | 44.44% |
| 2026-04-30 | $0.01B | $0.00B | 44.44% |
| 2026-01-31 | $0.01B | $0.00B | 50.00% |
| 2025-10-31 | $0.01B | $0.00B | 50.00% |
| 2025-07-31 | $0.01B | $0.00B | 50.00% |
| 2025-04-30 | $0.01B | $0.00B | 50.00% |
| 2025-01-31 | $0.01B | $0.00B | 50.00% |
| 2024-10-31 | $0.01B | $0.00B | 50.00% |
| 2024-07-31 | $0.01B | $0.00B | 40.00% |
| 2024-04-30 | $0.01B | $0.01B | 38.46% |
| 2024-01-31 | $0.02B | $0.01B | 31.25% |
| 2023-10-31 | $0.02B | $0.01B | 27.78% |
| 2023-07-31 | $0.02B | $0.01B | 26.32% |
| 2023-04-30 | $0.02B | $0.00B | 21.05% |
| 2023-01-31 | $0.02B | $0.00B | 21.05% |
| 2022-10-31 | $0.02B | $0.00B | 20.00% |
| 2022-07-31 | $0.02B | $0.00B | 19.05% |
| 2022-04-30 | $0.02B | $0.00B | 19.05% |
| 2022-01-31 | $0.02B | $0.00B | 19.05% |
| 2021-10-31 | $0.02B | $0.00B | 20.00% |
| 2021-07-31 | $0.02B | $0.00B | 21.05% |
| 2021-04-30 | $0.02B | $0.01B | 25.00% |
| 2021-01-31 | $0.02B | $0.01B | 28.57% |
| 2020-10-31 | $0.02B | $0.01B | 31.82% |
| 2020-07-31 | $0.02B | $0.01B | 36.36% |
| 2020-04-30 | $0.02B | $0.01B | 38.10% |
| 2020-01-31 | $0.02B | $0.01B | 40.00% |
| 2019-10-31 | $0.02B | $0.01B | 35.00% |
| 2019-07-31 | $0.02B | $0.01B | 33.33% |
| 2019-04-30 | $0.02B | $0.01B | 33.33% |
| 2019-01-31 | $0.02B | $0.01B | 30.00% |
| 2018-10-31 | $0.02B | $0.01B | 31.58% |
| 2018-07-31 | $0.01B | $0.01B | 35.71% |
| 2018-04-30 | $0.01B | $0.00B | 30.77% |
| 2018-01-31 | $0.01B | $0.00B | 30.77% |
| 2017-10-31 | $0.01B | $0.00B | 30.77% |
| 2017-07-31 | $0.02B | $0.00B | 23.53% |
| 2017-04-30 | $0.02B | $0.00B | 22.22% |
| 2017-01-31 | $0.02B | $0.01B | 26.32% |
| 2016-10-31 | $0.02B | $0.01B | 30.00% |
| 2016-07-31 | $0.02B | $0.01B | 33.33% |
| 2016-04-30 | $0.02B | $0.01B | 36.36% |
| 2016-01-31 | $0.02B | $0.01B | 36.36% |
| 2015-10-31 | $0.02B | $0.01B | 34.78% |
| 2015-07-31 | $0.02B | $0.01B | 33.33% |
| 2015-04-30 | $0.03B | $0.01B | 32.00% |
| 2015-01-31 | $0.03B | $0.01B | 29.63% |
| 2014-10-31 | $0.03B | $0.01B | 28.57% |
| 2014-07-31 | $0.03B | $0.01B | 30.00% |
| 2014-04-30 | $0.03B | $0.01B | 32.26% |
| 2014-01-31 | $0.03B | $0.01B | 34.38% |
| 2013-10-31 | $0.03B | $0.01B | 36.36% |
| 2013-07-31 | $0.03B | $0.01B | 37.50% |
| 2013-04-30 | $0.03B | $0.01B | 37.50% |
| 2013-01-31 | $0.03B | $0.01B | 35.48% |
| 2012-10-31 | $0.03B | $0.01B | 34.48% |
| 2012-07-31 | $0.03B | $0.01B | 33.33% |
| 2012-04-30 | $0.03B | $0.01B | 32.00% |
| 2012-01-31 | $0.02B | $0.01B | 34.78% |
| 2011-10-31 | $0.02B | $0.01B | 33.33% |
| 2011-07-31 | $0.02B | $0.01B | 33.33% |
| 2011-04-30 | $0.02B | $0.01B | 33.33% |
| 2011-01-31 | $0.01B | $0.00B | 30.77% |
| 2010-10-31 | $0.01B | $0.00B | 33.33% |
| 2010-07-31 | $0.01B | $0.01B | 50.00% |
| 2010-04-30 | $0.01B | $0.01B | 66.67% |
| 2010-01-31 | $0.01B | $0.01B | 83.33% |
| 2009-10-31 | $0.01B | $0.01B | 100.00% |
| 2009-07-31 | $0.01B | $0.01B | 100.00% |
| 2009-04-30 | $0.01B | $0.01B | 100.00% |
| 2009-01-31 | $0.02B | $0.02B | 100.00% |
| 2008-10-31 | $0.02B | $0.02B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Business Services | Consulting Services | $0.009B | $0.009B |
| Pharma-Bio Serv, Inc. provides consulting solutions to the pharmaceutical, chemical, medical device and biotechnology industries. Its services include regulatory compliance, validation, technology transfer, engineering, project management, process support, web pages, portals development, digital art design, intranets, extranets, software development, microbiological testing services, chemical testing services and technical trainings/seminars. The company operates in the U.S, Ireland and Spain. Pharma-Bio Serv, Inc. is headquartered in Dorado, Puerto Rico. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Equifax (EFX) | United States | $19.244B | 19.88 |
| Bureau Veritas Registre De Classification (BVRDF) | France | $14.189B | 0.00 |
| Gartner (IT) | United States | $12.097B | 13.31 |
| Booz Allen Hamilton Holding (BAH) | United States | $9.432B | 11.45 |
| Stantec (STN) | Canada | $7.914B | 17.01 |
| FTI Consulting (FCN) | United States | $4.007B | 17.19 |
| Exponent (EXPO) | United States | $3.234B | 30.50 |
| CBIZ (CBZ) | United States | $2.963B | 14.68 |
| Huron Consulting Group (HURN) | United States | $2.451B | 18.21 |
| Charles River Associates (CRAI) | United States | $1.032B | 19.88 |
| Hackett (HCKT) | United States | $0.273B | 10.88 |
| Information Services (III) | United States | $0.255B | 20.27 |
| Franklin Covey (FC) | United States | $0.201B | 24.74 |
| Accos (ACCL) | Hong Kong, SAR China | $0.040B | 0.00 |
| ATIF Holdings (ZBAI) | China | $0.011B | 0.00 |
| ATIF Holdings (AUC) | China | $0.009B | 0.00 |